Status | Study |
Withdrawn |
Study Name: Efficacy of Ezetimibe/Simvastatin 10/20 mg and MK0524A (1-2 g/Day) in Mixed Hyperlipidemia and Two or More Risk Factors Condition: Cardiovascular Diseases Hyperlipidemia Date: 2008-08-19 Interventions: Drug: ezetimibe/simvastatin 10/20 mg + placebo |
Completed |
Study Name: A Study of MK0859 in Patients With Primary Hypercholesterolemia or Mixed Hyperlipidemia (MK-0859-011)(COMPLETED) Condition: Hypercholesterolemia Hyperlipidemia Date: 2007-11-27 Interventions: Drug: MK0859 |
Completed |
Study Name: Effects of FXR Activation on Hepatic Lipid and Glucose Metabolism Condition: Metabolic Syndrome Familial Hypertriglyceridemia Date: 2007-04-24 Interventions: Drug: chenodeoxycholic acid ch |
Completed |
Study Name: Understanding the Genetic Basis of Familial Combined Hyperlipidemia in Mexican Individuals Condition: Hyperlipidemia, Familial Combined Coronary Disease Date: 2006-08-16 |
Completed |
Study Name: Efficacy Study of Extended-Release Niacin/Lovastatin Versus Usual Care Condition: Hyperlipidemia Mixed Hyperlipidemia Date: 2006-06-27 Interventions: Drug: Niacin Extended Release/Lovastatin |
Completed |
Study Name: Lipid Efficacy and Safety in Participants With Mixed Hyperlipidemia (MK-0524B-024) Condition: Mixed Hyperlipidemia Date: 2006-02-07 Interventions: Drug: MK-0524A Drug: Atorvastatin |
Completed |
Study Name: Lipid Efficacy Study (0524B-022)(COMPLETED) Condition: Primary Hypercholesterolemia Mixed Hyperlipidemia Date: 2005-12-21 Interventions: Drug: niacin (+) laropiprant (+) simvastatin |
Completed |
Study Name: Lipid Efficacy/Tolerability Study (0524A-020) Condition: Primary Hypercholesterolaemia Mixed Hyperlipidaemia Date: 2005-12-21 Interventions: Drug: niacin (+) laropiprant D |
Terminated |
Study Name: Carotid B-mode Ultrasound Study to Compare Anti-Atherosclerotic Effect of Torcetrapib/Atorvastatin to Atorvastatin. Condition: Mixed Hyperlipidemia Date: 2005-08-22 Interventions: Drug: torcetrapib/atorvastatin Drug: atorv |
Completed |
Study Name: A Study to Evaluate an Investigational Drug in Patients With Mixed Hyperlipidemia (0653A-071)(COMPLETED) Condition: Hyperlipidemia Hypercholesterolemia Hypertriglyceridemia Date: 2004-10-07 Interventions: Drug: ezetimibe (+) simvastatin Duration of Treatment: 6 months |